Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma Eur Radiol (2017) 27:3509–3522 DOI 10.1007/s00330-016-4653-3 MAGNETIC RESONANCE Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma 1,2 3 1 1 1 1 Jinhua Yu & Zhifeng Shi & Yuxi Lian & Zeju Li & Tongtong Liu & Yuan Gao & 1 3 3 Yuanyuan Wang & Liang Chen & Ying Mao Received: 12 July 2016 /Revised: 19 October 2016 /Accepted: 21 October 2016 /Published online: 21 December 2016 European Society of Radiology 2016 Abstract 0.74. Area under the receiver operating characteristic curve Objective The status of isocitrate dehydrogenase 1 (IDH1) is reached 0.86. Further validation on the independent cohort highly correlated with the development, treatment and prog- of 30 patients produced similar results. nosis of glioma. We explored a noninvasive method to reveal Conclusions Radiomics is a potentially useful approach for IDH1 status by using a quantitative radiomics approach for estimating IDH1 mutation status noninvasively using conven- grade II glioma. tional T2-FLAIR MRI images. The estimation accuracy could Methods A primary cohort consisting of 110 patients patho- potentially be improved by using multiple imaging modalities. logically diagnosed with grade II glioma was retrospectively Key Points studied. The radiomics method developed in this paper http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Radiology Springer Journals

Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma

Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/noninvasive-idh1-mutation-estimation-based-on-a-quantitative-radiomics-0l1aouu39h

References (39)

Publisher
Springer Journals
Copyright
Copyright © 2016 by European Society of Radiology
Subject
Medicine & Public Health; Imaging / Radiology; Diagnostic Radiology; Interventional Radiology; Neuroradiology; Ultrasound; Internal Medicine
ISSN
0938-7994
eISSN
1432-1084
DOI
10.1007/s00330-016-4653-3
pmid
28004160
Publisher site
See Article on Publisher Site

Abstract

Eur Radiol (2017) 27:3509–3522 DOI 10.1007/s00330-016-4653-3 MAGNETIC RESONANCE Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma 1,2 3 1 1 1 1 Jinhua Yu & Zhifeng Shi & Yuxi Lian & Zeju Li & Tongtong Liu & Yuan Gao & 1 3 3 Yuanyuan Wang & Liang Chen & Ying Mao Received: 12 July 2016 /Revised: 19 October 2016 /Accepted: 21 October 2016 /Published online: 21 December 2016 European Society of Radiology 2016 Abstract 0.74. Area under the receiver operating characteristic curve Objective The status of isocitrate dehydrogenase 1 (IDH1) is reached 0.86. Further validation on the independent cohort highly correlated with the development, treatment and prog- of 30 patients produced similar results. nosis of glioma. We explored a noninvasive method to reveal Conclusions Radiomics is a potentially useful approach for IDH1 status by using a quantitative radiomics approach for estimating IDH1 mutation status noninvasively using conven- grade II glioma. tional T2-FLAIR MRI images. The estimation accuracy could Methods A primary cohort consisting of 110 patients patho- potentially be improved by using multiple imaging modalities. logically diagnosed with grade II glioma was retrospectively Key Points studied. The radiomics method developed in this paper

Journal

European Radiology – Springer Journals

Published: Dec 21, 2016

There are no references for this article.